Status:
COMPLETED
Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX
Lead Sponsor:
Carl Zeiss Meditec AG
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
It is planned to implant the intraocular lenses XL Stabi ZO and Invent ZO into the eyes of patients for whom a cataract operation is medically indicated. The lenses are marketed and CE certified. Thei...
Eligibility Criteria
Inclusion
- Indication for cataract operation
- Written informed consent of patient after information
Exclusion
- Immobility
- Limited capacity of understanding
- Diseases that hamper a follow-up examination
- Astigmatism \>2.0 D
- Patients with ocular diseases who may be expected to show a vision of less than 0.63 (decimal) two months after cataract surgery with implantation of intraocular lens
- Complications during surgery, especially complications with positioning of the intraocular lens and with capsulorhexis
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00842959
Start Date
February 1 2009
End Date
January 1 2011
Last Update
June 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitäts-Augenklinik Mainz
Mainz, Germany, 55131